-
“Many people wonder how we’ve done in less than a year what usually takes at least 4-5 years. It is through getting rid of the dead space," said Dr Peter Marks, director of CBER, FDA
-
Different types of COVID-19 vaccines have been authorised and it's possible side effects will differ for each.
-
The social network said in a statement late on Monday that the move is taken after consultations with leading health organisations, including the WHO.
-
Hyderabad: Administrative Staff College of India (ASCI), Hyderabad, is organising an online ASCI public lecture on ‘Vaccine Development in India’ on Thursday. Principal Scientific Adviser, Government of India, Prof K Vijay Raghavan will deliver the lecture. K Padmanabhaiah, chairman, ASCI Court of Governors, and Dr Nirmalya Bagchi, ASCI director general (in-charge), will also take part […]
-
Govt must make public a clear set of rules on ‘how, where and who’ of getting the jabs to ensure there is no preferential treatment
-
According to the Turkish Health Ministry, the first doses will be given to over 1 million health workers across the country, followed by adults living in nursing homes, Xinhua news agency reported on Thursday.
-
After having received the government purchase order for 55 lakh doses, Bharat Biotech shipped the first batch of vaccines (each vial containing 20 doses) to Gannavaram, Guwahati, Patna, Delhi, Kurukshetra, Bengaluru
-
"Vaccines do offer the hope of shielding people from the disease, but return to the potential economic growth trajectory calls for determined efforts. Fortunately, we are on the positive side. The economy is picking up," said the Vice President
-
He also said whenever anyone raised eyebrows at the ability of the country and the countrymen, it has turned out to be wrong.
-
On the occasion of launching the Science and Technology Hyderabad Cluster along with Telangana Industries Minister KT Rama Rao, Raghavan said, “Hyderabad is an example of collection of institutions and industry comprising CSIR laboratories, Central University
-
In a note directed to Commissioners and Collectors, he said that the dry run programme will be conducted at six sites, three urban and three rural respectively.
-
We're grateful for all the scientists, researchers, manufacturing workers, and service members, who have worked tirelessly to make this breakthrough possible. It is truly a Christmas miracle, said the US president
-
The logistics intelligence platform is in talks with manufacturers, cold chain providers and governments
-
The assessment is part of UNICEF's work to lead on the procurement and delivery of Covid-19 vaccines for 92 low- and lower middle-income countries on behalf of the COVAX Facility, an international initiative
-
The report said home buying aspirations took a beating with the pandemic as conserving savings took precedence over buying a house
-
A handful of Microsoft partners, including Accenture, Avanade, EY and Mazik Global, are working on vaccine-management offerings which use Microsoft cloud services.
-
The Pfizer-BioNTech jab is one of several vaccines bringing hope for an end to the pandemic that has killed more than 1.5 million people worldwide and ravaged economies.
-
Biden is expected to make the announcement in coming days, along with choices for other key health posts, including head of the Centers for Disease Control and Prevention.
-
As production of the two vaccines expands, 20 million will be reached in December, 30 million in January and 50 million in February, making 100 million total.
-
The bill, which says the government will cover all vaccine costs for Japan's 126 million residents, was approved by the upper house of parliament, having cleared the powerful lower house.